Sandostatin uses in orthotopic ileal neobladder
Not Applicable
- Conditions
- bladder cancer.Malignant neoplasm of bladder
- Registration Number
- IRCT201101025527N1
- Lead Sponsor
- Vice Chancellery of Research of Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
invasive bladder carcinoma, no urethral involvement, patient consent to perform surgery in this manner
Exclusion criteria: urethral involvement in frozen section
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 24-hour urine Mucous volume. Timepoint: on days seven and twenty one after surgery. Method of measurement: 24-hour urine was collected and its mucus volume in gram was recorded.
- Secondary Outcome Measures
Name Time Method The number of washings. Timepoint: every 2 hours. Method of measurement: if urine flow become slow or urethral catheter blockage bladder irrigation is done & number of washings was recorded.;Average time for drying of dressing. Timepoint: daily visit. Method of measurement: with daily visit and scale day from surgery.